MYELO THERAPEUTICS GMBH
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2020
- $6.73M
- $6,728,096under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Jan 16, 2025
- SAM.gov registration
- Expired
- Registration expiration date Jan 14, 2026
Registration
- Entity structure
- International Organization
- Business start date
- Apr 18, 2013 (13 years)
- Location
- Berlin
- Website
- myelotherapeutics.com
† FY2026 obligations (provisional; DoD awards signed after Jul 30, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI G1LNCHNLYXF6. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2020. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2023: $219,300
- FY2022: $1,996,255
- FY2021: $2,519,309
- FY2020: $1,993,232
Total across 4 fiscal years: $6,728,096
Top awarding agencies
- Department of Health and Human Services$6,728,096, 100%
Top awarding sub-agencies
- National Institutes of Health$6,728,096, 100%
Top NAICS by obligations
Top product and service codes by obligations
- AN12Health r&d services; health care services; applied research$6,728,096, 100%
Capabilities
NAICS codes
- 541715E(primary)
SBA certifications
No certification in the SBA profile data.
Contracts
Latest awards and orders
- 75N93020C00005Definitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for MYELO THERAPEUTICS GMBH lists a physical address and a separate mailing address, along with 6 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
ROBERT-ROSSLE STRASSE 10
BERLIN, 13125
DEU
Mailing Address
ROBERT ROSSLE STR 10
BERLIN, 13125
DEU
Government Business Contact
DIRK PLEIMES
MANAGING DIRECTOR
ROBERT ROSSLE STR 10
BERLIN, BERLIN, 13125
DEU
Electronic Business Contact
PAULA MALLOY
GRANT MANAGER
ROBERT ROSSLE STR 10
BERLIN, BERLIN, 13125
DEU
Past Performance Contact
PAULA MALLOY
GRANT MANAGER
ROBERT ROSSLE STR 10
BERLIN, BERLIN, 13125
DEU
Government Business Alternate Contact
DIRK PLEIMES
MANAGING DIRECTOR
ROBERT ROSSLE STR 10
BERLIN, BERLIN, 13125
DEU
Electronic Business Alternate Contact
PAULA MALLOY
GRANT MANAGER
ROBERT ROSSLE STR 10
BERLIN, BERLIN, 13125
DEU
Past Performance Alternate Contact
0001 541715NNNN
0000
0000
E&Y
Additional Details
As of . Source: SAM.gov Entity Registration.
MYELO THERAPEUTICS GMBH has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires January 14, 2026.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation